Health Condition 1: B95-B97- Bacterial and viral infectious agents
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Dr Naman Shastri
Eligibility
Inclusion criteria
Inclusion criteria: Patients in ICUs with Central Line and/ or Peripheral Line without evidence of line site infection or thrombophlebitis and patients satisfying the eligibility criteria will be enrolled in the study Eligibility criteria: 1.Male and female participants aged between >= 18 years to 70 years or LAR who are willing to provide signed written informed consent 2.Agree to comply with the study requirements 3.Patients with BMI >=18-30 kg/m2 4.Patients with Central Line and/ or Peripheral Line without evidence of line site infection or thrombophlebitis.
Exclusion criteria
Exclusion criteria: 1.Patients currently suffering from fever 2.Patients having abnormal blood leucocyte count (both High and low) 3.Patients planned for transplant surgery 4.Pregnant or lactating women who intend to continue breast-feeding 5.HBV, HCV Or HIV result is positive 6.Any condition that, in the opinion of the investigator, does not justify the patientâ??s inclusion in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The difference in rate and time to onset of CRBSI between open and closed infusion containers.Timepoint: Baseline visit: Day of ICU admission Infection control practitioner (ICP) and or healthcare professional (HCP) will observe patients for CRBSI and will record 3 observations till discharge | — |
Secondary
| Measure | Time frame |
|---|---|
| Data on hand hygiene and vascular catheter care complianceTimepoint: ICP or HCP will observe health workers 3 times per week till discharge;Extra Length of Stay and mortalityTimepoint: Patient will be observed from ICU admission- till discharge | — |
Countries
India
Contacts
Public ContactDr Naman Shastri
EPIC Hospital
Outcome results
None listed